Cancer News and Research

Latest Cancer News and Research

Paper provides overview on preventing invasive cervical cancer

Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and The Ohio State University have published a paper in the September issue of Cancer Epidemiology, Biomarkers & Prevention that provides an overview on preventing invasive cervical cancer.

28 Sep 2012

Methodist Health System celebrates latest expansion in North Texas

Today Methodist Health System celebrated its latest expansion in North Texas during a groundbreaking ceremony for the Methodist Richardson Medical Center – Bush/Renner hospital.

28 Sep 2012

ARIAD Pharmaceuticals completes rolling submission of ponatinib NDA with FDA

ARIAD Pharmaceuticals, Inc. today announced it has completed the rolling submission of the New Drug Application (NDA) for its investigational BCR-ABL inhibitor, ponatinib, to the U.S. Food and Drug Administration (FDA).

28 Sep 2012

Life Technologies receives FDA clearance for OpTmizer CTS T-cell expansion media

Life Technologies Corporation today announced it has received FDA 510(k) clearance for its OpTmizer CTS T-Cell Expansion Tissue Culture Medium – a reagent that is now cleared as a Class II medical device and offers cost- and time-saving advantages for transitioning studies from the research bench to clinical trials.

28 Sep 2012

OncoGenex commences custirsen Phase 3 trial in non-small cell lung cancer

OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.

28 Sep 2012

Bayer HealthCare receives FDA approval for Stivarga to treat colorectal cancer

The U.S. Food and Drug Administration today approved Stivarga (regorafenib) to treat patients with colorectal cancer that has progressed after treatment and spread to other parts of the body (metastatic).

28 Sep 2012

Hundreds of new genes are involved in function and development of T-cells

A research team led by investigators at New York University and NYU School of Medicine has determined how cells that cause inflammatory ailments, such as Crohn's disease, multiple sclerosis, and arthritis, differentiate from stem cells and ultimately affect the clinical outcome of these diseases.

27 Sep 2012

George Mason University research makes big breakthrough in HIV

New research showing how the HIV virus targets "veterans" or memory T-cells could change how drugs are used to stop the virus, according to new research by George Mason University.

27 Sep 2012

Aeterna Zentari expects to file AEZS-130 NDA with FDA for adult growth hormone deficiency

Aeterna Zentaris Inc. today announced that it continues to expect to file a New Drug Application (NDA) early next year, for its oral ghrelin agonist, AEZS-130, as a diagnostic test for adult growth hormone deficiency (AGHD), after receiving notification from the United States Food and Drug Administration (FDA) that Fast Track designation had not been granted.

27 Sep 2012

Cancer Institute of New Jersey to benefit from Panera Bread's Pink Ribbon Bagel

For more than a decade, "thinking pink" has been a tradition for Panera Bread bakery-cafés in their effort to highlight breast cancer awareness in their local communities during the month of October. That campaign, which marks National Breast Cancer Awareness Month, continues this year, with the offering of the Pink Ribbon Bagel.

27 Sep 2012

Key bacterial protein structures reveal one of the biochemical secrets behind multi-drug tolerance

The structures of key bacterial proteins have revealed one of the biochemical secrets that enables bacteria to outwit antibiotics.

27 Sep 2012

Study identifies potential ways to minimize acrylamide levels in french fries

The process for preparing frozen, par-fried potato strips - distributed to some food outlets for making french fries - can influence the formation of acrylamide in the fries that people eat, a new study has found. Published in ACS' Journal of Agricultural and Food Chemistry, the study identifies potential ways of reducing levels of acrylamide, which the National Toxicology Program and the International Agency for Research on Cancer regard as a "probable human carcinogen."

27 Sep 2012

FIT in shape for new role in ulcerative colitis monitoring

Fecal immunochemical tests could allow noninvasive assessment of patients with ulcerative colitis, say the authors of a Japanese study.

27 Sep 2012

Sunshine vitamin affects cardiac outcomes

Vitamin D deficiency could increase the risk for ischemic heart disease, myocardial infarction, and early death, researchers suggest.

27 Sep 2012

High-dose, pulsed-dose BRT feasible palliative options in laryngeal cancer

High-dose and pulsed-dose brachytherapy are feasible options for laryngeal cancer patients with recurrent or residual stomal tumor after total laryngectomy, report Polish researchers.

27 Sep 2012

British Society for Immunology, Springer partner to publish six books per year

Springer and the British Society for Immunology (BSI) have entered into an agreement to publish six books per year, to be included in Springer's long-running book series, Advances in Experimental Medicine and Biology.

27 Sep 2012

Report illustrates safety and efficacy of transoral robotic surgery for supraglottic laryngectomy

Robotic surgery though the mouth is a safe and effective way to remove tumors of the throat and voice box, according to a study by head and neck cancer surgeons at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

27 Sep 2012

DNp63a protein employs epigenetics to keep cancer cells alive

Squamous cell carcinoma (SCC) is diagnosed in about 700,000 people in the United States every year. Commonly contributing to SCC is a protein called DNp63a - it goes abnormally high and the ability of a patient's body to kill cancer cells goes abnormally low. In many cases of SCC, it's just that simple. And science thought the function of DNp63a was simple, as well: the tumor suppressor gene p53 is responsible for recognizing and killing cancer cells, and in SCC, it's usually inactivated. It looked like high DNp63a repressed p53, made SCC.

27 Sep 2012

Hatch seeks more details from the Obama administration about federal exchanges

Sen. Orrin Hatch, R- Utah, charged that states can't make decisions about whether to pursue their own health insurance exchanges or to rely on the federal fallback version unless they have more information.

27 Sep 2012

Viewpoints: 'Redistribution' debate; Reducing delayed, missed and incorrect diagnoses

The Affordable Care Act, which levies new taxes on the wealthy to expand access to health care for the near poor, seems on track to become the biggest increase in government redistribution since the Johnson administration.

27 Sep 2012